| 000 | 01824naaaa2200313uu 4500 | ||
|---|---|---|---|
| 001 | https://directory.doabooks.org/handle/20.500.12854/40956 | ||
| 005 | 20220220035742.0 | ||
| 020 | _aintechopen.70971 | ||
| 020 | _a9781789236231 | ||
| 020 | _a9781789236224 | ||
| 024 | 7 |
_a10.5772/intechopen.70971 _cdoi |
|
| 041 | 0 | _aEnglish | |
| 042 | _adc | ||
| 100 | 1 |
_aMojca Božič-Mijovski _4auth |
|
| 245 | 1 | 0 | _aAnticoagulant Drugs |
| 260 |
_bIntechOpen _c2018 |
||
| 300 | _a1 electronic resource (120 p.) | ||
| 506 | 0 |
_aOpen Access _2star _fUnrestricted online access |
|
| 520 | _aAnticoagulant drugs are among the most frequently prescribed drugs in everyday clinical practice. In the past decades, several new direct oral anticoagulants were developed that changed the anticoagulant therapy landscape considerably. This book provides an extensive overview of all the known anticoagulants that can be useful for studying different aspects of the haemostatic system or as a starting point for new drug development. It is also a valuable tool for clinicians providing a description of the mode of action and management of therapy for anticoagulant drugs used in everyday clinical practice in different clinical settings, including direct oral anticoagulants dabigatran, rivaroxaban, apixaban and edoxaban. | ||
| 540 |
_aAll rights reserved _4http://oapen.org/content/about-rights |
||
| 546 | _aEnglish | ||
| 653 | _aToxicology and Pharmaceutical Science | ||
| 653 | _aPharmacology | ||
| 653 | _aPharmacokinetics | ||
| 653 | _aDrug Discovery | ||
| 653 | _aHealth Sciences | ||
| 856 | 4 | 0 |
_awww.oapen.org _uhttps://www.intechopen.com/books/anticoagulant-drugs _70 _zDOAB: download the publication |
| 856 | 4 | 0 |
_awww.oapen.org _uhttps://directory.doabooks.org/handle/20.500.12854/40956 _70 _zDOAB: description of the publication |
| 999 |
_c63714 _d63714 |
||